DIM-Journal Club: EBM 10 September 2013 08:20 Ort: Konferenzzimmer Haus 01/U142 Referent: Simon Wespi Olanzapine Versus Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Randomized Phase III Trial